The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.
Looking for leads, investment insights, or competitive intelligence?
News about AbbVie
Stocks are flourishing and IPOs abound.
AbbVie's victory is bad news for rival biotech giant Gilead.
If he pulls it off, he will make more than all of his peers combined.
A government watchdog will probe the orphan drug program.
After more than a year of public shaming.